VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 385 filers reported holding VANECK VECTORS ETF TR in Q4 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,000 | +25.0% | 122 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $4,000 | -42.9% | 122 | -45.0% | 0.00% | -50.0% |
Q3 2021 | $7,000 | -12.5% | 222 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $8,000 | +14.3% | 222 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $7,000 | +75.0% | 222 | +122.0% | 0.00% | +100.0% |
Q4 2020 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $4,000 | +100.0% | 100 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -75.0% | 100 | -71.4% | 0.00% | -100.0% |
Q1 2019 | $8,000 | +300.0% | 350 | +250.0% | 0.00% | – |
Q4 2018 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | -60.0% | 100 | -55.6% | 0.00% | -100.0% |
Q1 2018 | $5,000 | -37.5% | 225 | +12.5% | 0.00% | -50.0% |
Q4 2017 | $8,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |